Literature DB >> 21035272

Discrimination between patients with melancholic depression and healthy controls: comparison between 24-h cortisol profiles, the DST and the Dex/CRH test.

Georgios Paslakis1, Bertram Krumm, Maria Gilles, Ulrich Schweiger, Isabella Heuser, Inga Richter, Michael Deuschle.   

Abstract

Diurnal (24-h) cortisol profiles were compared to DST and Dex/CRH test outcomes with regard to their discriminative power in depressive disorder. With regard to several statistical measures (effect sizes, area under the curve) we found 24-h cortisol profiles to better discriminate between healthy controls and inpatients with the melancholic subtype of depression compared to the DST and Dex/CRH test. In search of a shortened time interval we found the 2-h time window 1000-1200 h of the cortisol profile to be the one with the highest sensitivity (83.3%) and specificity (87.9%). The specificity of the DST was 93.3% and somewhat higher than that of the cortisol profiles and the Dex/CRH test (87.9% and 78.8.%, respectively). However, the sensitivity of the DST was very low (30.8%), in fact similar to that of the Dex/CRH test (30.8%), but much lower than that of the 1000-1200 h interval (83.3%). The assessment of cortisol in plasma is an easy to perform, cost-saving method for the evaluation of the HPA system activity, which may have a series of clinical and scientific implications for the depressive disorder.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035272     DOI: 10.1016/j.psyneuen.2010.10.002

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  9 in total

Review 1.  Hypothalamic-pituitary-adrenal axis dysfunction as a neurobiological correlate of emotion dysregulation in adolescent suicide.

Authors:  María Dolores Braquehais; María Dolores Picouto; Miquel Casas; Leo Sher
Journal:  World J Pediatr       Date:  2012-08-12       Impact factor: 2.764

2.  Biological outcome measurements for behavioral interventions in multiple sclerosis.

Authors:  Anja Fischer; Christoph Heesen; Stefan M Gold
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

3.  Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder.

Authors:  Richard Musil; Florian Seemüller; Sebastian Meyer; Ilja Spellmann; Mazda Adli; Michael Bauer; Klaus-Thomas Kronmüller; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Robert Fisher; Wolfgang Gaebel; Rebecca Schennach; Hans-Jürgen Möller; Michael Riedel
Journal:  Int J Methods Psychiatr Res       Date:  2017-06-14       Impact factor: 4.035

Review 4.  Neurovascular glucocorticoid receptors and glucocorticoids: implications in health, neurological disorders and drug therapy.

Authors:  Sherice Williams; Chaitali Ghosh
Journal:  Drug Discov Today       Date:  2019-09-18       Impact factor: 7.851

5.  Modulation of c-Jun N-terminal kinase signaling and specific glucocorticoid receptor phosphorylation in the treatment of major depression.

Authors:  Milica J Jovicic; Iva Lukic; Marija Radojcic; Miroslav Adzic; Nadja P Maric
Journal:  Med Hypotheses       Date:  2015-06-02       Impact factor: 1.538

6.  Evaluation of the HPA Axis' Response to Pharmacological Challenges in Experimental and Clinical Early-Life Stress-Associated Depression.

Authors:  Nayara Cobra Barreiro Barroca; Cristiane Von Werne Baes; Camila Maria Severi Martins-Monteverde; Nayanne Beckmann Bosaipo; Marcia Santos da Silva Umeoka; Julian Tejada; José Antunes-Rodrigues; Margaret de Castro; Mario Francisco Juruena; Norberto Garcia-Cairasco; Eduardo Henrique de Lima Umeoka
Journal:  eNeuro       Date:  2021-01-15

7.  Relative metabolic stability, but disrupted circadian cortisol secretion during the fasting month of Ramadan.

Authors:  Suhad Bahijri; Anwar Borai; Ghada Ajabnoor; Altaf Abdul Khaliq; Ibrahim AlQassas; Dhafer Al-Shehri; George Chrousos
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

8.  Early Life Stress in Depressive Patients: HPA Axis Response to GR and MR Agonist.

Authors:  Cristiane von Werne Baes; Camila Maria Severi Martins; Sandra Márcia de Carvalho Tofoli; Mário Francisco Juruena
Journal:  Front Psychiatry       Date:  2014-01-24       Impact factor: 4.157

Review 9.  Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder.

Authors:  Juan Joseph Young; Tim Silber; Davide Bruno; Isaac Robert Galatzer-Levy; Nunzio Pomara; Charles Raymond Marmar
Journal:  Front Psychiatry       Date:  2016-04-25       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.